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Abstract
We investigated Ca2+ handling in isolated brain synaptic and nonsynaptic mitochondria and in 
cultured striatal neurons from the YAC128 mouse model of Huntington’s disease (HD). Both 
synaptic and nonsynaptic mitochondria from 2- and 12-month-old YAC128 mice had larger Ca2+ 
uptake capacity than mitochondria from YAC18 and wild-type FVB/NJ mice. Synaptic 
mitochondria from 12-month-old YAC128 mice had further augmented Ca2+ capacity compared 
with mitochondria from 2-month-old YAC128 mice and age-matched YAC18 and FVB/NJ mice. 
This increase in Ca2+ uptake capacity correlated with an increase in the amount of mutant 
huntingtin protein (mHtt) associated with mitochondria from 12-month-old YAC128 mice. We 
speculate that this may happen due to mHtt-mediated sequestration of free fatty acids thereby 
increasing resistance of mitochondria to Ca2+-induced damage. In experiments with striatal 
neurons from YAC128 and FVB/NJ mice, brief exposure to 25 or 100μM glutamate produced 
transient elevations in cytosolic Ca2+ followed by recovery to near resting levels. Following 
recovery of cytosolic Ca2+, mitochondrial depolarization with FCCP produced comparable 
elevations in cytosolic Ca2+, suggesting similar Ca2+ release and, consequently, Ca2+ loads in 
neuronal mitochondria from YAC128 and FVB/NJ mice. Together, our data argue against a 
detrimental effect of mHtt on Ca2+ handling in brain mitochondria of YAC128 mice.
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Introduction
Huntington’s disease (HD) is a hereditary neurodegenerative disorder linked to a mutation in 
a single gene encoding huntingtin protein (Htt) (MacDonald et al. 1993). Although a 
causative link between this mutation and HD pathogenesis is well documented, the precise 
molecular mechanisms of the detrimental effect of mutant huntingtin (mHtt) remain obscure. 
One of the major hypotheses posits that mHtt leads to abnormalities in Ca2+ signaling in 
affected neurons (Bezprozvanny and Hayden 2004) probably due to augmented activity of 
the NMDA-subtype of glutamate receptors (Zhang et al. 2008), aberrations in inositol 1,4,5-
trisphosphate (IP3) receptor function (Tang et al. 2003), and defects in mitochondrial Ca2+ 
handling (Panov et al. 2002).
Mitochondria possess Ca2+ channels in the inner membrane (Baughman et al. 2011; De et 
al. 2011) that allow Ca2+ influx into mitochondria and Ca2+ accumulation in the 
mitochondrial matrix (Bernardi 1999). In early studies, investigators found decreased Ca2+ 
uptake capacity in brain mitochondria from YAC72 mice and a rat HD model (Panov et al. 
2002; Gellerich et al. 2008) and in mitochondria of a conditionally immortalized striatal 
progenitor cell line STHQ111/Q111 expressing mHtt with 111 glutamines (Milakovic et al. 
2006; Lim et al. 2008). It is well established that the magnitude of mitochondrial Ca2+ 
uptake capacity is limited by sensitivity of mitochondria to the detrimental effect of Ca2+ 
(Chalmers and Nicholls 2003). A large Ca2+ load in mitochondria induces mitochondrial 
damage manifested in induction of the permeability transition pore (PTP) that causes 
mitochondrial swelling and depolarization (Bernardi 1999). This limits the ability of 
mitochondria to accumulate Ca2+, produce ATP, and retain pro-apoptotic proteins like 
cytochrome c (Rasola and Bernardi 2011). Consequently, facilitated PTP induction in 
mitochondria associated with mHtt was proposed to explain Ca2+ handling defects in 
mitochondria from HD animal and cell models (Milakovic et al. 2006; Gellerich et al. 
2008). Indeed, increased propensity to Ca2+-stimulated PTP induction was found in 
mitochondria in neurons from HD mice and immortalized striatal cells (Choo et al. 2004; 
Fernandes et al. 2007; Lim et al. 2008; Quintanilla et al. 2013). On the other hand, in our 
previous study, we did not find an increased likelihood of PTP induction in striatal and 
cortical mitochondria isolated from HD mice compared to mitochondria from wild-type 
mice (Brustovetsky et al. 2005). Later, Oliveira et al. (2007) demonstrated increased Ca2+ 
uptake capacity in brain nonsynaptic mitochondria isolated from R6/2 and YAC128 mice 
compared to mitochondria from wild-type littermates (Oliveira et al. 2007). Moreover, in 
experiments with cultured cortical neurons expressing N-terminal or full-length mHtt, 
investigators failed to find a significant effect of mHtt on mitochondrial Ca2+ accumulation 
following exposure of neurons to excitotoxic glutamate (Chang et al. 2006). Thus, the 
question of whether mHtt increases sensitivity of brain mitochondria and, particularly, 
neuronal mitochondria to Ca2+-induced damage remains open.
In the present study, we investigated whether mHtt facilitates PTP induction and examined 
the effect of mHtt on Ca2+ uptake capacity in synaptic and nonsynaptic mitochondria 
isolated from YAC128, YAC18, and wild-type FVB/NJ mice. Consistent with our previous 
data (Brustovetsky et al. 2005), our current results do not support facilitated PTP induction 
in brain mitochondria from YAC128 mice. Both synaptic and nonsynaptic mitochondria 
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isolated from early symptomatic 2-month-old YAC128 mice had larger Ca2+ uptake 
capacity than mitochondria from age-matched YAC18 and FVB/NJ mice consistent with the 
previous report by Oliveira et al. (2007) (Oliveira et al. 2007). Moreover, synaptic 
mitochondria from late-stage symptomatic 12-month-old YAC128 mice had even greater 
Ca2+ uptake capacity compared with mitochondria from 2-month-old YAC128 mice and 
age-matched YAC18 and FVB/NJ mice. The augmented Ca2+ uptake capacity of synaptic 
mitochondria from 12-month-old YAC128 mice correlated with an increased amount of 
mHtt associated with mitochondria. Finally, in experiments with glutamate-exposed striatal 
neurons from YAC128 and FVB/NJ mice, we found no evidence for mHtt-induced 
impairment of mitochondrial Ca2+ accumulation.
Materials and Methods
Materials
Pyruvate, malate, succinate, glutamate, EGTA, ADP, oligomycin, rotenone, antimycin A, 
2,4-dinitrophenol, N-methyl-D-glucamine and carbonylcyanide-p-trifluorometh-
oxyphenylhydrazone (FCCP) were purchased from Sigma (St. Louis, MO, USA). 
Tetraphenylphosphonium chloride was from Fluka (Buchs, Switzerland). Percoll was from 
GE Healthcare Bio-Sciences (Pittsburgh, PA, USA). Bovine serum albumin (BSA), free 
from free fatty acids, was from MP Biomedicals (Irvine, CA, USA). Alamethicin was from 
Enzo (Farmingdale, NY, USA).
Animals
All procedures with animals were performed in accordance with the Institutional Animal 
Care and Use Committee approved protocol. Transgenic YAC18 and YAC128 mice as well 
as wild-type FVB/NJ mice were purchased from Jackson Laboratories (Bar Harbor, ME) 
and breeding colonies were established in Laboratory Animal Resource Center at Indiana 
University School of Medicine, Indianapolis, IN. YAC128 mice express full-length human 
mHtt containing 128 glutamines in the polyglutamine (polyQ) stretch in addition to wild-
type mouse Htt whereas YAC18 mice express full-length human Htt containing 18 
glutamines (Hodgson et al. 1996; Hodgson et al. 1999). Male YAC18 and YAC128 mice 
were bred with female FVB/NJ mice (background strain). The mice were housed under 
standard conditions with free access to water and food. Previously, it was reported that 
YAC128 mice at 2 months of age begin to show behavioral abnormalities and are 
considered to be early symptomatic (Van Raamsdonk et al. 2005a; Van Raamsdonk et al. 
2005b). A recent study using electron microscopy demonstrated a significant reduction in 
excitatory synapses of striatal neurons in 12-month-old YAC128 mice (Singaraja et al. 
2011). At 12 months of age, YAC128 mice show significant striatal loss and are considered 
to be at an advanced stage of HD pathology (Slow et al. 2003). Therefore, we were 
interested in assessing mitochondrial Ca2+ handling in mice at both ages. Consequently, in 
our experiments, we used early symptomatic 2-month-old and mature 12-month-old 
YAC128 mice, control age-matched YAC18 mice, and their age-matched wild-type FVB/NJ 
littermates of both sexes.
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Genotyping
All offspring were genotyped with a PCR assay on tail DNA. Briefly, PCR of tail DNA was 
performed according to the protocol provided by Jackson Laboratory using oligonucleotide 
primers oIMR6533 (GGCTGA GGAAGCTGAGGAG) and TmoIMR1594 
(CCGCTCAGGTTCTGCTTTTA) purchased from Invitrogen. The PCR reaction mixture 
contained 1μl DNA template and 23μl Platinum PCR SuperMix (Invitrogen) supplemented 
with 0.39μM of each primer (Invitrogen), total volume 25μl. Cycling conditions were 5 min 
at 95°C, 35 cycles at 30 sec at 95°C, 30 sec at 56°C, 60 sec at 72°C, and 10 min at 72°C. 
Reaction products were analyzed on 1.2% agarose gel run at 100V for 60 min with Tris-
acetate-EDTA running buffer containing 1X GelRed™ Nucleic Acid Gel Stain (Biotium, 
CA).
Isolation of brain nonsynaptic and synaptic mitochondria
Percoll gradient-purified brain nonsynaptic and synaptic mitochondria from YAC128, 
YAC18 and wild-type FVB/NJ mice were isolated as we described previously (Brustovetsky 
et al. 2002; Shalbuyeva et al. 2007). The scheme illustrating the procedure for isolation and 
purification of synaptic and nonsynaptic mitochondria is shown in Supplemental Figure 1, 
and a brief description is in the Figure legend. Supplemental Figure 2 illustrates the distinct 
separation of nonsynaptic mitochondria and synaptosomes. Synaptosomes are further used 
to release synaptic mitochondria.
Nonsynaptic mitochondria are from neuronal somata and glial cells, whereas synaptic 
mitochondria are of pure neuronal origin and derived from nerve terminals (synaptosomes). 
The use of both types of mitochondria allows a complete assessment of brain mitochondrial 
functions. While Ca2+ uptake capacity of nonsynaptic mitochondria from YAC128 mice has 
been previously assessed (Oliveira et al. 2007), Ca2+ uptake capacity of synaptic 
mitochondria was evaluated for the first time in our study. Earlier, it was hypothesized that 
BSA can displace mHtt from its binding sites on mitochondria (Panov et al. 2003). 
Therefore, BSA was omitted from all solutions used in our experiments with isolated 
mitochondria unless stated otherwise.
Mitochondrial Ca2+ uptake capacity
Mitochondrial Ca2+ uptake was measured with a miniature Ca2+-selective electrode in a 0.3 
ml chamber at 37°C under continuous stirring. A decrease in the external Ca2+ concentration 
indicated mitochondrial Ca2+ uptake. The standard incubation medium contained 125 mM 
KCl, 0.5 mM MgCl2, 3 mM KH2PO4, 10 mM Hepes, pH 7.4, 10μM EGTA, and was 
supplemented either with 3 mM pyruvate plus 1 mM malate or 3 mM succinate plus 3 mM 
glutamate. Here and in other experiments, succinate was used in combination with glutamate 
to prevent oxaloacetate inhibition of succinate dehydrogenase (Lehninger et al. 1993). 
Additionally, the incubation medium was supplemented with 0.1 mM ADP and 1μM 
oligomycin as described previously (Chalmers and Nicholls 2003). Ca2+ was added to 
mitochondria as 10μM CaCl2 pulses. Data were quantified as Ca2+ uptake capacity per mg 
of mitochondrial protein.
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Mitochondrial swelling and membrane potential
Mitochondrial swelling was evaluated at 37°C and continuous stirring by following changes 
in light scattering of mitochondrial suspension at 525 nm with an incident light beam at 180° 
in a 0.3 ml chamber. The incubation medium for light scattering measurements contained 
215 mM mannitol, 70 mM sucrose, 0.5 mM MgCl2, 3 mM KH2PO4, 10 mM Hepes, pH 7.4, 
10μM EGTA, 3 mM succinate, 3 mM glutamate. A decrease in light scattering of 
mitochondrial suspension indicated mitochondrial swelling. Maximal mitochondrial 
swelling was induced by alamethicin (30μg/ml). Maximal swelling was taken as 100%. 
Ca2+-induced swelling was calculated as a percentage of maximal swelling (Li et al. 2010). 
Mitochondrial membrane potential was measured in a standard KCl-based incubation 
medium at 37°C with a tetraphenylphosphonium (TPP+) electrode by following TPP+ 
distribution between the incubation medium and mitochondria (Kamo et al. 1979). A 
decrease in external TPP+ concentration corresponds to mitochondrial polarization, while an 
increase of TPP+ in the incubation medium corresponds to depolarization.
Mitochondrial reactive oxygen species production
Reactive oxygen species (ROS) production by mitochondria was monitored at 37°C in the 
standard KCl-based incubation medium with Amplex Red assay for H2O2 (Molecular 
Probes, Eugene, OR) using a Perkin-Elmer LS 55 luminescence spectrometer and excitation/
emission wavelengths 550/590 nm as described previously (Votyakova and Reynolds 2001).
Immunoblotting
Isolated mitochondria pretreated with Protease Inhibitor Cocktail (Roche) were solubilized 
by incubation in NuPAGE LDS sample buffer (Invitrogen, Carlsbad, CA) supplemented 
with a reducing agent at 70°C for 15 minutes. Bis-Tris gels (4–12%, Invitrogen) and Tris-
Acetate gels (3–8%, Invitrogen) were used for electrophoresis (40μg protein per lane). After 
SDS-PAGE, proteins were transferred to Hybond-ECL nitrocellulose membrane (Amersham 
Biosciences). Blots were incubated for 1 hour at room temperature in blocking solution of 
5% dry milk, phosphate-buffered saline, pH 7.2, and 0.15% Triton X-100. Then, where 
indicated, blots were incubated with one of the following primary antibodies: mouse 
monoclonal anti-polyQ 1C2 (mAb1574, Millipore, 1:1000), specific for mHtt; mouse 
monoclonal anti-cyclophilin D (EMD, San Diego, CA, 1:1000); rabbit monoclonal anti-
MEK1/2 (Pierce, Rockford, IL, 1:1000); rabbit polyclonal anti-VDAC1 (Calbiochem, 
1:1000); rabbit polyclonal anti-calnexin (Abcam, Cambridge, MA, 1:1000); and mouse 
monoclonal anti-COX IV (Life Technologies, Grand Island, NY, 1:2000). To assess 
neuronal and glial populations in cell cultures, cells were lysed in Tris Buffer Saline (TBS) 
supplemented with 1% Nonidet P-40 and Protease Inhibitor Cocktail (Roche) by incubating 
for 15 minutes on ice. Then, cell lysates were centrifuged at 35,000 rpm (100,000×g) for 30 
minutes. Aliquots of supernate were supplemented with NuPAGE LDS sample buffer 
(Invitrogen, Carlsbad, CA), containing a reducing agent, incubated at 70°C for 15 minutes, 
and then tested by western blotting with mouse monoclonal anti-MAP2 antibody, rabbit 
polyclonal anti-GFAP antibody (Millipore, Temecula, CA, 1:1000), and mouse monoclonal 
anti-GAPDH antibody (Abcam, Cambridge, MA, 1:2000). Blots were incubated with goat 
anti-mouse or goat anti-rabbit IgG (1:20000) coupled with horseradish peroxidase (Jackson 
Pellman et al. Page 5
J Neurochem. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
ImmunoResearch Laboratories, West Grove, PA, USA) and developed with Supersignal 
West Pico chemiluminescent reagents (Pierce, Rockford, IL). Molecular mass markers See 
Blue Plus 2 Standards (5μl) and HiMark Pre-stained High Molecular Weight Protein 
Standards (10μl) (Invitrogen) were used to determine molecular masses of the bands. NIH 
ImageJ 1.48v software (http://rsb.info.nih.gov//ij) was used to quantify band densities
Cell culturing
Striatal neuronal cultures were prepared from individual striata of postnatal day 1 YAC128 
mice and their wild-type littermates as previously described (Dubinsky 1993), but without 
pooling cells from different animals together. We used neuronal-glial co-culture derived 
from postnatal day 1 mouse pups because it is more physiologically relevant and allows for 
the study of more mature, better developed cells than pure neuronal culture derived from 
embryonic animals. For all platings, 35 mg·ml−1 uridine plus 15 mg·ml−1 5-fluoro-2′-
deoxyuridine were added 24 hours after plating to inhibit proliferation of non-neuronal cells. 
Neurons were cultured in a 5% CO2 atmosphere at 37°C in Neurobasal medium with B27 
supplement (Life Technologies).
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde for 15 minutes. Then, cells were incubated with 
Protein-Free Blocking Buffer (Pierce, Rockford, IL) for an hour at room temperature. Cells 
were incubated overnight with primary antibodies anti-MAP2 (neuronal marker, mouse 
monoclonal, Millipore, Temecula, CA, 1:500), anti-GFAP (astroglial marker, rabbit 
polyclonal, Millipore, Temecula, CA, 1:1000), anti-DARPP-32 (marker of medium spiny 
neurons, rabbit monoclonal, Pierce, Rockford, IL, 1:200), and anti-GABA (rabbit 
polyclonal, Pierce, Rockford, IL, 1:20000). Nuclei were stained with DAPI (nuclear marker, 
Invitrogen, Carlsbad, CA). Then, cells were incubated with secondary donkey anti-mouse 
antibody conjugated with AlexaFluor 488 and donkey anti-rabbit AlexaFluor 568 
(Invitrogen, Carlsbad, CA, 1:1000). Bright field and fluorescence images were acquired 
using a Nikon Eclipse TE2000-U inverted microscope equipped with a Nikon CFI Super 
Fluoro 20× 0.75 NA objective and CCD camera Cool SNAPHQ (Roper Scientific, Tucson, 
AZ) controlled by MetaMorph 6.3 software (Molecular Devices, Downingtown, PA).
Calcium imaging
To follow changes in cytosolic Ca2+, striatal neurons (10–12 days in vitro, DIV) were 
loaded at 37°C with 2.6μM Fura-2FF-AM (Molecular Probes, Eugene, OR) in the standard 
bath solution containing 139 mM NaCl, 3 mM KCl, 0.8 mM MgCl2, 1.8 mM CaCl2, 10 mM 
NaHEPES, pH 7.4, and 5 mM glucose. The osmolarity of the bath solutions was similar to 
that in the growth medium (280 mosm). Osmolarity of the bath solution was measured with 
an osmometer, Osmette II™ (Precision Systems Inc., Natick, MA). Fluorescence imaging 
was performed with an inverted microscope, Nikon Eclipse TE2000-S, using a Nikon CFI 
Plan Fluor 20× 0.45 NA objective and a back-thinned EM-CCD camera Hamamatsu 
C9100-12 (Hamamatsu Photonic Systems, Bridgewater, NJ) controlled by Simple PCI 
software 6.1 (Compix Inc., Sewickley, PA). The excitation light was delivered by a 
Lambda-LS system (Sutter Instruments, Novato, CA). The excitation filters (340±5 and 
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380±7) were controlled by a Lambda 10-2 optical filter changer (Sutter Instruments, Novato, 
CA). Fluorescence was recorded through a 505 nm dichroic mirror at 535±25 nm. The 
images were taken every 15 seconds during the time-course of the experiment using the 
minimal exposure time that provided acceptable image quality. The changes in cytosolic 
Ca2+ concentration ([Ca2+]c) were monitored by following a ratio of F340/F380, calculated 
after subtracting the background from both channels. After 1.5 minutes of fluorescence 
recording in the standard bath solution, glutamate (25 or 100μM) plus 10μM glycine was 
applied to the neurons. At the end of the experiment, the bath solution with glutamate and 
Ca2+ was replaced by a glutamate- and Ca2+-free solution, Na+ was replaced by equimolar 
N-methyl-D-glucamine (NMDG) and 1μM FCCP was applied to the neurons to depolarize 
neuronal mitochondria and to release Ca2+ accumulated in mitochondria. Quantification of 
Fura-2FF signals was carried out per manufacturer instructions. [Ca2+]c was calculated using 
the Grynkiewicz method (Grynkiewicz et al. 1985), assuming Kd for Fura-2FF is 5.5μM. In 
all experiments, the fluorescence background was subtracted from the signals. Since Ca2+ 
binding and spectroscopic properties of fluorescent dyes can differ significantly in the 
intracellular milieu, the cytosolic Ca2+ concentrations presented in this paper should be 
deemed estimates as stated previously by other investigators (Dietz et al. 2007; Stanika et al. 
2009).
Statistics
Data are shown as mean ± SEM of several independent experiments. Statistical analysis of 
the experimental results consisted of unpaired t-test or one-way ANOVA followed by 
Bonferroni’s post hoc test (GraphPad Prism® 4.0, GraphPad Software Inc., SanDiego, CA, 
USA). Every experiment was performed using several different preparations of isolated 
mitochondria or several separate neuronal-glial platings.
RESULTS
In the majority of our experiments, we used both synaptic and nonsynaptic mitochondria 
isolated from YAC128 mice and their wild-type littermates, FVB/NJ mice. Previously, it 
was reported that in vivo exposure to 3-nitropropionic acid, a mitochondrial toxin that 
inhibits succinate dehydrogenase (Alston et al. 1977) and simulates some aspects of HD in 
animal models (Palfi et al. 1996), alters corticostriatal synaptic activity (Mendoza et al. 
2014). Synaptic deficiency in HD is well established (Sepers and Raymond 2014). 
Corticostriatal synaptic abnormalities in YAC128 mice were seen at 1 month of age (Joshi et 
al. 2009). Synaptic dysfunction was observed in 1.5- to 2-month-old YAC128 mice 
(Milnerwood and Raymond 2007). On the other hand, synaptic activity in medium spiny 
neurons from 12-month-old YAC128 mice was significantly reduced (Joshi et al. 2009). 
Consistent with this, a recent study using electron microscopy demonstrated a significant 
reduction in excitatory synapses onto striatal neurons in 12-month-old YAC128 mice 
(Singaraja et al. 2011). Therefore, to determine the mechanisms of synaptic deficiency in 
YAC128 mice, it is essential to establish whether mHtt impairs synaptic mitochondria in 
these animals.
Pellman et al. Page 7
J Neurochem. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Following isolation and discontinuous Percoll-gradient purification, both synaptic and 
nonsynaptic mitochondria from YAC128 mice were tested for purity. The purity of isolated 
mitochondria was assessed by western blotting with antibodies against calnexin (an 
endoplasmic reticulum marker), MEK1/2 (a cytosolic marker), and COX IV (a 
mitochondrial marker). The purity control data are shown in Figure 1A. These data show the 
lack of endoplasmic reticulum and cytosolic contaminations in synaptic and nonsynaptic 
mitochondria isolated and purified from FVB/NJ and YAC128 mice. Since mHtt is 
predominantly localized in the cytosol, our data confirm that if mHtt is detected in 
mitochondrial fractions, it is not due to cytosolic contamination.
Both synaptic and nonsynaptic mitochondria from YAC128 mice retained attached mHtt 
that could not be washed out after 30 minutes of incubation at 37°C in the standard KCl-
based incubation medium with or without 0.1% BSA (Fig. 1B–E). On the other hand, alkali 
treatment for 30 minutes at pH 11.5, previously used to remove mHtt from mitochondrial 
membranes (Choo et al. 2004), decreased mHtt level below the detection limit of western 
blotting (Fig. 1B–E). The western blotting data were quantified using NIH ImageJ software 
and presented as a mHtt/VDAC ratio. These data are consistent with the previous findings 
obtained in an early study, demonstrating mHtt association with mitochondria (Choo et al. 
2004).
Earlier, some investigators reported an increased propensity to PTP induction in 
mitochondria exposed to mHtt (Choo et al. 2004; Fernandes et al. 2007; Lim et al. 2008; 
Quintanilla et al. 2013). However, in our previous study we did not find evidence for 
increased susceptibility to PTP induction in striatal and cortical mitochondria from HD mice 
compared with mitochondria from wild-type mice (Brustovetsky et al. 2005). In this earlier 
study, we investigated PTP induction in nonsynaptic mitochondria. In the present study, we 
for the first time tested synaptic (neuronal) mitochondria from YAC128 and wild-type 
FVB/NJ mice (Fig. 2). Mitochondrial swelling and depolarization are the major 
manifestations of PTP induction (Bernardi 1999). Consequently, we investigated an 
induction of the PTP by simultaneously monitoring a decrease in light scattering of the 
mitochondrial suspension, indicative of swelling of the organelles, and a release of TPP+ 
from mitochondria, indicative of mitochondrial depolarization. Ca2+, in a concentration-
dependent manner, induced swelling and depolarization of synaptic mitochondria (Fig. 2). 
To quantify swelling of mitochondria, at the end of the experiment we applied alamethicin 
(AL), an antibiotic that causes maximal mitochondrial swelling (Brustovetsky and Dubinsky 
2000b). Maximal swelling was taken as 100% and mitochondrial swelling following 15 
minutes incubation with Ca2+ was calculated as a percentage of maximal swelling. Both 
mitochondrial swelling and depolarization in response to Ca2+ were comparable in 
mitochondria isolated from YAC128 and wild-type mice. Thus, in our experiments mHtt 
failed to increase propensity to PTP induction in synaptic (neuronal) mitochondria from 
YAC128 mice.
Next, we tested the effect of mHtt on Ca2+ uptake capacity of mitochondria isolated from 
YAC128 mice and compared it with Ca2+ uptake capacity of mitochondria from YAC18 and 
wild-type FVB/NJ mice. A possible decrease in mitochondrial Ca2+ uptake capacity could 
serve as an indicator of mitochondrial impairment in HD. Conversely, unchanged or 
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augmented Ca2+ uptake capacity suggests a lack of defects in mitochondrial Ca2+ handling. 
In our hands, Ca2+ uptake capacity of nonsynaptic mitochondria from 2- and 12-month-old 
YAC128 mice was slightly but statistically significantly increased compared with 
mitochondria from YAC18 and FVB/NJ mice (Fig. 3). This result is consistent with data 
previously reported by Oliveira et al (2007) (Oliveira et al. 2007). The slight increase in 
Ca2+ uptake capacity was observed with both Complex I substrates pyruvate/malate and the 
Complex II substrate succinate used in combination with glutamate to prevent accumulation 
of oxaloacetate and inhibition of succinate dehydrogenase (Brustovetsky and Dubinsky 
2000a). Synaptic mitochondria from 2-month-old YAC128 mice also had a slight but 
statistically significant increase in Ca2+ uptake capacity compared with mitochondria from 
age-matched YAC18 and FVB/NJ mice regardless of oxidative substrates (Fig. 4A, D). BSA 
(Fig. 4B) and cyclosporin A (not shown) considerably increased Ca2+ uptake capacity in 
synaptic mitochondria from all mouse strains tested. Interestingly, Ca2+ uptake capacity of 
synaptic mitochondria from 12-month-old YAC128 mice was noticeably increased 
compared with mitochondria from 2-month-old YAC128 mice and age-matched 12-month-
old YAC18 and FVB/NJ mice (Fig. 4C). These experiments also showed that Ca2+ uptake 
capacity of mitochondria from YAC18 mice was indistinguishable from Ca2+ capacity of 
mitochondria derived from FVB/NJ mice. Therefore, in the following experiments we used 
only mitochondria from YAC128 and wild-type FVB/NJ mice.
Previously, it was reported that the level of cyclophilin D (CyD), a key regulatory 
component of the PTP that sensitizes the pore to Ca2+ (Baines et al. 2005; Schinzel et al. 
2005), was reduced in mitochondria from older animals (Eliseev et al. 2007). Therefore, we 
tested whether the increased Ca2+ uptake capacity in mitochondria from YAC128 mice, 
particularly, in synaptic mitochondria from 12-month-old transgenic animals, correlates with 
a decrease in CyD. Our experiments revealed a lack of difference in the amount of CyD in 
synaptic and nonsynaptic mitochondria from 2- and 12-month-old YAC128 and FVB/NJ 
mice (Suppl. Fig. 3). Consequently, this could not explain increased Ca2+ uptake capacity in 
mitochondria from YAC128 mice compared with mitochondria from wild-type animals.
ROS are major activators of the PTP (Bernardi 1999) and PTP induction is the key factor 
that restricts Ca2+ uptake capacity (Chalmers and Nicholls 2003). It seemed conceivable that 
different levels of ROS production could underlie the difference in Ca2+ uptake capacity. 
Therefore, in the following experiments we examined mitochondrial H2O2 generation by 
synaptic mitochondria from YAC128 and FVB/NJ mice using the Amplex Red assay 
(Brustovetsky et al. 2003). With succinate plus glutamate, ROS generation was much higher 
than with pyruvate plus malate. BSA further augmented ROS generation (Fig. 5A, B), 
presumably due to an increase in membrane potential in both YAC128 and wild-type 
mitochondria that may lead to an increase in ROS generation (Korshunov et al. 1997). Ca2+, 
on the other hand, depolarizes mitochondria (Bernardi 1999) and, consequently, inhibited 
ROS generation with succinate plus glutamate (Fig. 5C), but did not significantly change 
ROS generation in the presence of pyruvate plus malate (Fig. 5D). Importantly, there was no 
difference in ROS generation between mitochondria from YAC128 and FVB/NJ mice. 
Figure 5E shows a statistical analysis of ROS measurements. Thus, ROS production could 
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not account for the difference in Ca2+ uptake capacity between mitochondria from 
transgenic and wild-type animals.
Next, we examined the level of mHtt associated with mitochondria and found a 2-fold 
increase in the amount of mHtt bound to synaptic mitochondria from 12-month-old YAC128 
mice compared with mitochondria from 2-month-old YAC128 mice (Fig. 6A, B). This 
increase was not due to an increase in cytosolic mHtt because it remained at the same level 
(Fig. 6C, D). Thus, augmented Ca2+ uptake capacity of synaptic mitochondria from 12-
month-old YAC128 mice correlated with the increased amount of mHtt associated with 
these mitochondria.
Finally, we evaluated accumulation of Ca2+ in mitochondria of striatal neurons exposed to 
excitotoxic glutamate. Previously, this approach was used in studies with cortical neurons, 
expressing mHtt (Chang et al. 2006). In our experiments, we used striatal neurons in culture 
derived from individual postnatal day 1 (PN1) YAC128 and FVB/NJ mouse pups. The 
viability of cultured striatal neurons derived from these animals was tested using propidium 
iodide staining for dead neurons and calcein-AM staining for live neurons and found to be 
similar: at 10–12 DIV 91±3% of neurons from FVB/NJ mice and 93±4% of neurons from 
YAC128 mice were alive. Suppl. Figure 4A shows the representative bright-field image of 
cell culture used in our experiments. All pups used for harvesting neurons were genotyped 
and cultured cells were tested for the presence of mHtt using western blotting (Suppl. Fig. 
4B). The cell culture contained both neurons and astrocytes stained by neuronal marker 
MAP2 (green) and glial marker GFAP (red) (Mao and Wang 2001), respectively (Suppl. 
Fig. 4D). To determine consistency in glia/neuron ratio, we performed western blotting with 
antibodies against MAP2 and GFAP. GAPDH was used as a loading control. Then, we 
performed densitometry and calculated MAP2/GFAP ratio as a characteristic of our cell 
cultures (Suppl. Fig. 5). These experiments showed very small variability (mean±SEM: 
1.10±0.08 for FVB/NJ mice, N=6, and 1.12±0.07 for YAC128 mice, N=6) between different 
platings as well as the lack of difference between cell cultures prepared from YAC128 and 
wild-type littermates.
Judging by staining with anti-GABA antibody the majority of striatal neurons (85%) were 
GABA positive, typical for striatal neurons (Ivkovic and Ehrlich 1999; Mao and Wang 
2001), (Fig. Suppl. 4F) and 50% of all cells were positive for DARPP32, a marker for 
medium spiny neurons (Ivkovic and Ehrlich 1999) (Suppl. Fig. 4H). Supplemental Figures 
4C, E, and G show bright-field images for the corresponding immunofluorescence images. 
In calcium imaging experiments, we used short applications of 25 and 100μM glutamate 
(plus 10μM glycine) and evaluated subsequent release of mitochondrial Ca2+ into the 
cytosol following depolarization of the organelles with 1μM FCCP (Fig. 7). The magnitude 
of elevation in cytosolic Ca2+ due to Ca2+ release from mitochondria was used to evaluate 
mitochondrial Ca2+ uptake capacity in situ (Chang et al. 2006). Simultaneously with FCCP 
application, we replaced external Na+ for N-methyl-D-glucamine (NMDG), a bulk organic 
cation that cannot be transported by Na+/Ca2+ exchanger and hence prevents Ca2+ extrusion 
from the cell by this mechanism. In these experiments, glutamate applications produced 
transient increases in cytosolic Ca2+ followed by recovery of cytosolic Ca2+ to near resting 
level after removal of glutamate (Fig. 7). Neurons from YAC128 mice had a more robust 
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response to glutamate. Zhang et al (2008) also reported elevated cytosolic Ca2+ in response 
to glutamate in YAC128 medium spiny neurons (Zhang et al. 2008). Depolarization of 
mitochondria with 1μM FCCP in Ca2+-free bath solution (to prevent influx of external Ca2+) 
triggered a massive increase in cytosolic Ca2+ that was similar in neurons from both 
YAC128 and wild-type mice (Fig. 7). This result suggests that mHtt does not decrease the 
ability of neuronal mitochondria to accumulate Ca2+ and, therefore, most likely does not 
affect mitochondrial contribution to maintenance of Ca2+ homeostasis in striatal neurons 
exposed to excitotoxic glutamate. Overall, the presented results demonstrate the lack of 
difference in mitochondrial Ca2+ accumulation in isolated mitochondria and cultured 
neurons from YAC128 and FVB/NJ mice, suggesting similar sensitivity to deleterious Ca2+ 
and comparable propensity to PTP induction.
DISCUSSION
In earlier studies, mitochondrial dysfunction and a decreased ability of mitochondria to 
accumulate Ca2+ have been proposed to contribute to HD pathogenesis (Panov et al. 2002; 
Choo et al. 2004; Milakovic et al. 2006). On the other hand, in experiments with 
nonsynaptic mitochondria, we and other investigators failed to find an increase in sensitivity 
to deleterious Ca2+ and instead observed an increase in resistance to Ca2+ that was 
manifested in reduced propensity to PTP induction and augmented Ca2+ uptake capacity 
(Brustovetsky et al. 2005; Oliveira et al. 2007). In the present study, we demonstrated that 
both synaptic and nonsynaptic mitochondria isolated from YAC128 mice retain their ability 
to accumulate Ca2+ compared with mitochondria from wild-type animals. Moreover, 
mitochondria from YAC128 mice, especially synaptic mitochondria from 12-month-old 
animals, had larger Ca2+ uptake capacity compared with mitochondria from wild-type 
littermates. The augmented Ca2+ uptake capacity of synaptic mitochondria from 12-month-
old YAC128 mice correlated with an increased amount of mHtt associated with these 
mitochondria. Notably, an increased amount of full-length mHtt was also found to be 
associated with brain nonsynaptic mitochondria isolated from 12-month-old knock-in 150Q/
150Q mice compared with younger knock-in animals (Orr et al. 2008). Finally, following 
application of excitotoxic glutamate to cultured striatal neurons from YAC128 mice, 
neuronal mitochondria accumulated similar amounts of Ca2+ compared with mitochondria in 
striatal neurons from wild-type animals. Thus, mHtt failed to reduce Ca2+ uptake capacity in 
brain mitochondria from YAC128 mice. On the contrary, the level of mHtt binding to 
mitochondria positively correlates with mitochondrial resistance to deleterious Ca2+.
In our experiments we found that BSA increased Ca2+ uptake capacity of brain 
mitochondria isolated from both YAC128 mice and their wild-type littermates. It is known 
that ROS production by mitochondria, oxidizing succinate, depends on the reverse electron 
flow in the mitochondrial electron transport chain that brings electrons back to Complex I. 
The reverse electron flow, in turn, depends on mitochondrial membrane potential: 
hyperpolarization leads to an increase in reverse electron flow and, subsequently, to elevated 
ROS production (Korshunov et al. 1997; Korshunov et al. 1998). It is well established that 
ROS increase propensity to PTP induction in mitochondria (Zoratti and Szabo 1995). 
However, it is also known that free fatty acids (FFA) increase propensity of PTP induction 
as well (Zoratti and Szabo 1995). BSA binds FFA (Spector 1975) and exerts a strong 
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protective effect against PTP (see Fig. 5 and (Wieckowski et al. 2000)). Based on these 
observations, our data concerning BSA effects suggest that the protective action of BSA 
prevails over deleterious effect of augmented ROS generation.
Over the last 15 years, studies from several laboratories implicated mHtt in facilitating PTP 
induction and impairment of mitochondrial Ca2+ accumulation (Panov et al. 2002; Choo et 
al. 2004; Milakovic et al. 2006; Gizatullina et al. 2006; Fernandes et al. 2007; Lim et al. 
2008; Gellerich et al. 2008; Quintanilla et al. 2013). An early report by Panov et al. 
presented data that suggested bioenergetic abnormalities and a decrease in Ca2+ 
accumulation by mitochondria exposed to mHtt (Panov et al. 2002). Because inhibition of 
the PTP with cyclosporin A and ADP failed to eliminate the difference between 
mitochondria from wild-type and HD mice, PTP involvement was ruled out. The effect of 
mHtt on mitochondrial Ca2+ uptake capacity appeared to be elusive and in a subsequent 
paper Panov et al. reported that “the defect in Ca2+ handling in brain mitochondria was 
consistently observed only if brain mitochondria were isolated without BSA” (Panov et al. 
2003). The authors presumed that BSA could displace mHtt from its binding sites on 
mitochondria. Our data do not support this hypothesis. We found that mHtt is associated 
with mitochondria, consistent with previous reports (Choo et al. 2004), but BSA does not 
displace mHtt from mitochondria.
In our earlier study, we did not observe an increased predisposition to Ca2+-induced PTP 
induction in striatal and cortical nonsynaptic mitochondria from HD mice compared with 
mitochondria from wild-type littermates (Brustovetsky et al. 2005). On the contrary, we 
found increased resistance to Ca2+ in striatal mitochondria exposed to mHtt. Consistent with 
our findings, Oliveira et al. reported that nonsynaptic mitochondria from R6/2 and YAC128 
mice had increased Ca2+ uptake capacity compared with mitochondria from wild-type 
animals (Oliveira et al. 2007). Both our study (Brustovetsky et al. 2005) and a study by 
Oliveira et al. (Oliveira et al. 2007) suggested the lack of mHtt-induced impairment of 
mitochondrial Ca2+ handling, argued against facilitation of PTP induction by mHtt, and did 
not support involvement of PTP in HD pathogenesis. In line with this, Perry et al. found that 
R6/2 mice crossed with CyD-knockout mice and, thus, expressing reduced or no CyD, had 
increased neuronal mitochondrial Ca2+ uptake capacity without a sign of improvement in 
either behavioral or neuropathological features of HD (Perry et al. 2010). The authors 
concluded that increased Ca2+ capacity of neuronal mitochondria is not beneficial in R6/2 
mice. Chang et al. exposed neurons expressing N-terminal mHtt to glutamate and used 
FCCP-induced depolarization of mitochondria to release accumulated Ca2+ (Chang et al. 
2006). The authors failed to find a significant effect of mHtt on the ability of neuronal 
mitochondria to accumulate Ca2+ following exposure of neurons to excitotoxic glutamate. 
Recently, Wang et al. stimulated Ca2+ mobilization in medium spiny neurons by activating 
group I metabotropic glutamate receptors and triggering IP3 production and found 
significantly higher Ca2+ load in mitochondria in neurons from YAC128 mice compared 
with neurons from wild-type mice (Wang et al. 2013). Overall, these data strongly argue 
against mHtt-induced impairment of mitochondrial Ca2+ uptake and facilitated PTP 
induction, and their role in HD pathogenesis. Thus, there are two distinct views on the 
possible mHtt-induced impairment of mitochondrial Ca2+ handling. One group of 
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investigators postulates mHtt-induced facilitation of PTP induction, leading to defects in 
mitochondrial Ca2+ uptake, whereas the other group does not find evidence for these 
detrimental mHtt effects. The reason for this discrepancy is not clear, but it might be related 
to the use of different HD models and variations in methodological approaches.
In our present study, we did not find evidence of impaired Ca2+ uptake capacity in either 
synaptic or nonsynaptic mitochondria from YAC128 mice. On the contrary, both types of 
mitochondria had increased Ca2+ capacity, especially, synaptic mitochondria from 12-
month-old YAC128 mice. The mechanism underlying augmented Ca2+ uptake capacity of 
mitochondria that are associated with increased levels of mHtt is unknown. At the moment, 
we can only speculate about a possible scenario. Mitochondrial Ca2+ uptake capacity mainly 
depends on the ability of mitochondria to resist an induction of the PTP (Chalmers and 
Nicholls 2003). Induction of the PTP causes mitochondrial depolarization that precludes 
further Ca2+ uptake and results in a release of previously accumulated Ca2+ (Rasola and 
Bernardi 2011). It is known that FFA are effective activators of PTP (Zoratti and Szabo 
1995) and FFA binding by BSA (Spector 1975) most likely underlies BSA-mediated 
protection against PTP induction (Wieckowski et al. 2000). In our experiments, BSA 
significantly increased Ca2+ uptake capacity of synaptic (Fig. 5B) and nonsynaptic (not 
shown) mitochondria from 2-month-old FVB/NJ, YAC18, and YAC128 mice. Furthermore, 
in experiments with 12-month-old mice, we found that BSA significantly increased Ca2+ 
uptake capacity of mitochondria from FVB/NJ mice, but was ineffective in mitochondria 
from YAC128 mice (Fig. 5C). Keeping in mind the increased amount of mHtt associated 
with mitochondria from 12-month-old YAC128 mice and elevated Ca2+ uptake capacity in 
these mitochondria, the lack of further augmentation with BSA suggests that mHtt and BSA 
effects may have a similar mechanism, e.g. binding of FFA. Although additional 
experiments are necessary to test this hypothesis and untangle the potential mechanism of 
FFA binding to mHtt, existing literature lends support to this notion. It was reported that in 
Fatty-Acid-Binding Proteins (FABPs), a family of intracellular proteins that bind FFA, 
arginine and tryptophan form H-bonds directly with fatty acids, whereas glutamine interacts 
with fatty acids through two intervening water molecules (Hamilton 2002). Because mHtt 
has a large number of glutamines, it is conceivable that mHtt may interact with FFA more 
strongly than wild-type Htt and potentially may sequester FFA. Alternatively, the elongated 
polyQ stretch in mHtt might result in a change in mHtt conformation, leading to increased 
ability of mHtt to bind FFA. However, these hypotheses require further experimental testing.
The increased Ca2+ uptake capacity of mitochondria from YAC128 mice may reflect 
compensatory adaptation to augmented Ca2+ influx via overactivated NMDA receptors 
and/or increased Ca2+ release from endoplasmic reticulum via abnormally activated IP3 
receptors (Bezprozvanny and Hayden 2004). Similar to findings by Chang et al. and Wang 
et al. (Chang et al. 2006; Wang et al. 2013), in experiments with cultured striatal neurons 
from YAC128 mice and wild-type littermates, we did not find evidence of the decreased 
ability of neuronal mitochondria to accumulate Ca2+. Consequently, comparable 
susceptibility to PTP induction and the lack of mHtt-induced deficiency in mitochondrial 
Ca2+ uptake capacity in mitochondria from YAC128 and wild-type mice argue against 
possible involvement of these mechanisms in HD pathogenesis.
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Figure 1. Purity of synaptic and nonsynaptic mitochondria isolated from YAC128 and wild-type 
FVB/NJ mice (A). Detection of human mutant huntingtin (mHtt) in brain nonsynaptic (A) and 
synaptic (B) mitochondria isolated from YAC128 mice (B–E)
In A, homogenates, cytosolic and mitochondrial fractions were analyzed using western 
blotting with antibodies against calnexin (ER marker), MEK1/2 (cytosolic marker), and 
COXIV (mitochondrial marker). Fractions were solubilized and proteins were resolved by 
SDS-PAGE using 4–12% Bis-Tris gels as described in Materials and Methods. In B and D, 
mitochondria (Mtc) were analyzed immediately after isolation (Mtc from ice), after 30 
minutes of incubation in the standard incubation medium supplemented with 3 mM 
succinate and 3 mM glutamate without (washing) and with 0.1% BSA, free from fatty acids, 
(washing with BSA), and after 30 minutes of incubation at pH 11.5 (alkali treatment). 
Mitochondrial porin (voltage-dependent anion channel, VDAC) was used as a loading 
control. In C and E, the western blotting data were quantified using NIH ImageJ software 
and presented as a mHtt/VDAC ratio. Data are mean±SEM, *p<0.01 compared with 
mitochondria from ice and after washing, N=7.
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Figure 2. Ca2+-induced mitochondrial swelling and depolarization in synaptic mitochondria 
from wild-type FVB/NJ (A, C, E) and YAC128 (B, D, F) mice
Mitochondrial swelling was evaluated by following a decline in light scattering of 
mitochondrial suspension (red traces). A decrease in light scattering indicates mitochondrial 
swelling. Changes in mitochondrial membrane potential were evaluated by following 
distribution of tetraphenylphosphonium (TPP+) between incubation medium and 
mitochondrial matrix (black traces). The decrease in TPP+ concentration in the incubation 
medium ([TPP+]ext) indicates TPP+ accumulation in mitochondria and high membrane 
potential. The release of TPP+ from mitochondria indicates a decrease in membrane 
potential. Mitochondrial swelling and membrane potential were evaluated simultaneously at 
37°C. Where indicated 25, 50, or 100μM Ca2+ was applied to mitochondria (Mtc). At the 
end of the experiments, 60μM 2,4-dinitrophenol (2,4-DNP) was applied to completely 
depolarize mitochondria and, then, 30μg/ml alamethicin (AL) was added to induce maximal 
mitochondrial swelling, taken as 100%. The amount of Ca2+-induced swelling was 
determined as percentage of maximal swelling (shown in A as X%). In G, percentage of 
Ca2+-induced mitochondrial swelling. Data are mean±SEM, N=8.
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Figure 3. Ca2+ uptake capacity of brain nonsynaptic mitochondria isolated from YAC128, 
YAC18, and wild-type FVB/NJ mice
Mitochondria were incubated at 37°C in the standard incubation medium supplemented 
either with 3 mM succinate plus 3 mM glutamate or with 3 mM pyruvate plus 1 mM malate 
as indicated in the Figure. In all Ca2+ uptake experiments, 100μM ADP and 1μM 
oligomycin were present in the incubation medium. In A and B, mitochondria were isolated 
from 2-month-old mice. In C, mitochondria were isolated from 12-month-old mice. In A–C, 
where indicated 10μM Ca2+ pulses were applied to mitochondria until mitochondria fail to 
uptake additional Ca2+. In D, statistical analysis of Ca2+ uptake capacity of mitochondria 
from YAC128, YAC18, and wild-type FVB/NJ mice. Data are mean±SEM, *p<0.05 
compared with mitochondria from FVB/NJ and YAC18 mitochondria, N=9.
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Figure 4. Ca2+ uptake capacity of brain synaptic mitochondria isolated from YAC128, YAC18, 
and wild-type FVB/NJ mice
Mitochondria were incubated at 37°C in the standard incubation medium supplemented 
either with 3 mM succinate plus 3 mM glutamate or with 3 mM pyruvate plus 1 mM malate 
as indicated in the Figure. In all Ca2+ uptake experiments, 100μM ADP and 1μM 
oligomycin were present in the incubation medium. In B, incubation medium was 
additionally supplemented with 0.1% BSA (free from fatty acids). In A, B, and D, 
mitochondria were isolated from 2-month-old mice. In C, mitochondria were isolated from 
12-month-old mice. In A–D, where indicated 10μM Ca2+ pulses were applied to 
mitochondria until mitochondria fail to uptake additional Ca2+. In E, statistical analysis of 
Ca2+ uptake capacity of mitochondria from YAC128, YAC18, and wild-type FVB/NJ mice. 
Data are mean±SEM, *p<0.05 comparing with FVB/NJ and YAC18 mitochondria; 
**p<0.01 compared with mitochondria from 12-month-old FVB/NJ and YAC18 mice, N=9.
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Figure 5. H2O2 production by synaptic mitochondria from 2-month-old YAC128 and wild-type 
FVB/NJ mice
Mitochondrial H2O2 production was measured under continuous stirring in 0.4 ml cuvette at 
37°C in the standard KCl-based incubation medium. In A–C, the standard incubation 
medium was supplemented with 3 mM succinate plus 3 mM glutamate. In D, the incubation 
medium was supplemented with 3 mM pyruvate plus 1 mM malate. In B, 0.1% BSA (free 
from fatty acids) was present in the medium. In C and D, 12.5 or 200μM Ca2+ was applied 
to mitochondria, respectively, as indicated. In E, statistical analysis of H2O2 production 
under different experimental conditions. Data are mean±SEM, N=11. *p<0.01 compared 
with H2O2 generation by wild-type mitochondria oxidizing succinate plus glutamate, but 
without BSA and Ca2+; #p<0.01 compared with H2O2 generation by YAC128 mitochondria 
oxidizing succinate plus glutamate, but without BSA and Ca2+.
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Figure 6. The level of mutant huntingtin (mHtt) associated with brain mitochondria isolated 
from 2- and 12-month-old YAC128 and wild-type FVB/NJ mice
In A, western blots of brain synaptic mitochondria from 2- and 12-month-old YAC128 and 
wild-type FVB/NJ mice with anti-polyQ 1C2 antibody, specific for mHtt. Isolated 
mitochondria were solubilized and proteins were resolved by SDS-PAGE using 3–8% Tris-
acetate gels. Calnexin was used as a marker of endoplasmic reticulum. MEK1/2 was used as 
a cytosolic marker. Mitochondrial porin (voltage-dependent anion channel, VDAC) was 
used as a mitochondrial marker and loading control. In B, statistical analysis of western blot 
densitometry with data expressed as a ratio of mHtt band intensity to band intensity of 
VDAC. Data are mean±SEM, *p<0.05 compared with mitochondria from 2-month-old 
YAC128 mice, N=8. In C, western blots of brain cytosolic fractions from 2- and 12-month-
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old FVB/NJ and YAC128 mice with anti-polyQ 1C2 antibody, specific for mHtt. Cytosolic 
fractions were resolved by SDS-PAGE using 3–8% Tris-acetate gels. MEK1/2 was used as a 
cytosolic marker and loading control. In D, statistical analysis of western blot densitometry 
with data expressed as a ratio of mHtt band intensity to band intensity of MEK1/2. Data are 
mean±SEM, N=8.
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Figure 7. triatal neurons from YAC128 and wild-type FVB/NJ mice have comparable 
mitochondrial Ca2+ accumulation following transient glutamate-induced elevations in cytosolic 
Ca2+
In A, B, E, and F, the averaged fluorescence signals (mean±SEM) from the representative 
experiments are shown. Cytosolic Ca2+ was followed by monitoring Fura-2FF F340/F380 
fluorescence ratio at 37°C. In these experiments, striatal neurons (10–12 DIV) were exposed 
to 25μM or 100μM glutamate (in both cases, with 10μM glycine) for 2 minutes as indicated. 
Then, glutamate and glycine were removed to let [Ca2+]c recover. After [Ca2+]c reached 
near resting level (7 minutes after glutamate removal) neurons were treated with 1μM FCCP 
to depolarize mitochondria and release accumulated Ca2+. To avoid ambiguity concerning 
possible Ca2+ influx from the outside of the cell, external Ca2+ was removed simultaneously 
with glutamate and glycine. In addition, to prevent Ca2+ extrusion from the cell by Na+/Ca2+ 
exchanger, the external Na+ was replaced by equimolar N-methyl-D-glucamine (NMDG) as 
indicated. In C, D, G, and H, the areas under the curve (AUC) for the averaged fluorescence 
signals are shown. The AUC for glutamate-induced increase in [Ca2+]c (Glu AUC) was 
calculated for the 120 second period beginning with glutamate application. The AUC for 
FCCP-induced increase in [Ca2+]c (FCCP Glu) was calculated for the 300 second period 
following FCCP application. Data are mean± SEM. In C, *p<0.05 compared with wild-type 
cells, N=8–9 separate experiments with 20–25 individual neurons in each experiment.
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